Compare Stocks → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AEMDNASDAQ:NVCNOTCMKTS:RDGLNYSE:RMED Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.43-5.1%$1.65$1.33▼$5.00$3.74M1.888,526 shs15,531 shsNVCNNeovasc$30.03$29.69$4.59▼$30.07$82.28M1.756,993 shs1 shsRDGLVivos$0.12$0.08$0.04▼$0.12$46.63M1.531.21 million shs1.06 million shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-1.76%+6.22%-14.11%-16.50%-61.92%NVCNNeovasc0.00%0.00%0.00%0.00%0.00%RDGLVivos+1.61%+16.29%+67.69%+88.23%+47.12%RMEDRa Medical Systems0.00%0.00%0.00%0.00%-54.66%Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical1.6401 of 5 stars3.53.00.00.01.90.00.6NVCNNeovascN/AN/AN/AN/AN/AN/AN/AN/ARDGLVivosN/AN/AN/AN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical3.00Buy$10.00601.26% UpsideNVCNNeovascN/AN/AN/AN/ARDGLVivosN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/ACurrent Analyst RatingsLatest AEMD, RMED, NVCN, and RDGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/4/2024AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $10.00(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K6.55N/AN/A$6.56 per share0.22NVCNNeovasc$3.81M21.60N/AN/A$5.77 per share5.20RDGLVivos$20K2,331.28N/AN/A($0.02) per share-6.00RMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.03M-$4.99N/AN/AN/AN/A-106.28%-86.60%6/26/2024 (Estimated)NVCNNeovasc-$41.20M-$15.08N/A∞N/A-1,082.92%-127.25%-80.31%N/ARDGLVivos-$2.89MN/A0.00∞N/A-9,524.89%N/A-180.12%5/2/2024 (Estimated)RMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ALatest AEMD, RMED, NVCN, and RDGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/18/2024Q4 2023RDGLVivosN/A-$0.01-$0.01-$0.01N/AN/A2/14/2024Q3 2024AEMDAethlon Medical-$1.23-$1.37-$0.14-$1.37N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ANVCNNeovascN/AN/AN/AN/AN/ARDGLVivosN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.933.93NVCNNeovasc0.802.962.85RDGLVivosN/A6.576.57RMEDRa Medical SystemsN/A2.862.85OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%NVCNNeovasc1.64%RDGLVivosN/ARMEDRa Medical Systems11.00%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical4.00%NVCNNeovascN/ARDGLVivos18.50%RMEDRa Medical Systems18.62%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical152.62 million2.52 millionOptionableNVCNNeovasc492.74 millionN/ANot OptionableRDGLVivos1388.87 million316.93 millionNot OptionableRMEDRa Medical Systems145.37 million4.37 millionNot OptionableAEMD, RMED, NVCN, and RDGL HeadlinesSourceHeadlineDietary Interventions Reduce CVD Risk in RA and SpAajmc.com - March 8 at 7:57 PMAlert1 Medical Alert System Review: What Experts Say (2024)forbes.com - February 20 at 9:27 PMRa Medical Systems Inc.thestreet.com - February 15 at 10:42 AMCatheter Precision Inc (VTAK)investing.com - February 11 at 11:09 PMVTAK Catheter Precision, Inc.seekingalpha.com - January 19 at 6:41 PMWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By Doctorsmsn.com - January 7 at 11:58 PMCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Qfinance.yahoo.com - August 25 at 6:53 PMReminder: Ra Medical Systems Announces Name and Ticker Symbol Changesfinance.yahoo.com - August 17 at 9:15 AMRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device Patentfinanznachrichten.de - August 16 at 6:14 PMRa Medical Systems Announces Milestone Achievement for Electrophysiology Divisionfinance.yahoo.com - August 7 at 12:14 PMRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol Changesfinanznachrichten.de - August 2 at 8:13 AMRa Medical says demand is rising for its non-invasive electrophysiology mapping systemmassdevice.com - July 24 at 5:15 PMRa Medical Systems, Inc.: Ra Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinanznachrichten.de - July 24 at 12:14 PMRa Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinance.yahoo.com - July 24 at 12:14 PMRa Medical Systems, Inc.: RMED's LockeT Device Utilized in Structural Heart Proceduresfinanznachrichten.de - July 6 at 10:17 AMRMED's LockeT Device Utilized in Structural Heart Proceduresfinance.yahoo.com - July 6 at 10:17 AMInvesting in Ra Medical Systems Inc (RMED): What You Must Knowknoxdaily.com - July 5 at 6:18 PMRa Medical Systems, Inc.: RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finanznachrichten.de - June 28 at 9:07 AMRMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finance.yahoo.com - June 28 at 9:07 AMRa Medical Systems, Inc.: Ra Medical's Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinanznachrichten.de - June 12 at 4:10 PMRa Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinance.yahoo.com - June 12 at 4:10 PMMedical Device Co. Completes Merger in Q1/23investorideas.com - June 9 at 9:35 PMRa Medical Systems reports Q1 resultsmsn.com - June 5 at 10:34 AMRa Medical Systems, Inc.: Ra Medical Systems Announces First Quarter Resultsfinanznachrichten.de - June 2 at 9:16 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesKeurig Dr Pepper Reaffirms Its Guidance, Time to Buy? April 1, 2024 6:15 AMView Keurig Dr Pepper Reaffirms Its Guidance, Time to Buy? When Will the Next Bull Market Be?April 15, 2024 9:25 AMView When Will the Next Bull Market Be?All Headlines Company DescriptionsAethlon MedicalNASDAQ:AEMDAethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.NeovascNASDAQ:NVCNNeovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.VivosOTCMKTS:RDGLVivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.Ra Medical SystemsNYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.